Chemours Company (The) ($CC) Stock Forecast: Up 5.0% Today

What is Chemours Company (The)?

Chemours Company (CC) is a specialty chemical maker currently facing legal and environmental controversies, particularly related to PFAS contamination.

Why is Chemours Company (The) going up?

CC stock is up 5.0% on Mar 23, 2026 14:50

• The North Carolina Supreme Court reviewing a lawsuit against DuPont and Chemours may have introduced legal uncertainties and risks for the company, impacting market sentiment initially.
• An investigation into potential securities fraud by the Portnoy Law Firm following disappointing financial results likely contributed to CC's stock price decline.
• The subsequent increase in CC's stock price may be linked to three analyst firms raising their price targets for the company, indicating improved sentiment and potentially attracting more institutional investors.
• The strong intraday surge and outperformance of the S&P 500 suggest a positive short-term market response to the raised price targets and overall analyst enthusiasm, despite CC's enduring financial challenges and environmental issues.

CC Price Chart

CC Technical Analysis

CC News

Top NC court will consider Jackson’s lawsuit against DuPont, Chemours

The North Carolina Supreme Court will consider Attorney General Jeff Jackson's environmental contamination lawsuit against DuPont and Chemours, a decision made five months after granting a temporary stay to the companies. The court's 5-2 ruling, split along party lines, will review a lower court ruling favoring Jackson, with Republican justices remaining silent on the decision while Democratic justices expressed strong dissent. The core legal issue revolves around whether the Attorney General has the authority to pursue a separate lawsuit beyond actions already taken by state environmental regulators.

https://www.carolinajournal.com/top-nc-court-will-consider-jacksons-lawsuit-against-dupont-chemours/

The Chemours Company Investigated by the Portnoy Law Firm

The Portnoy Law Firm has launched an investigation into The Chemours Company (NYSE: CC) over potential securities fraud after its stock price plummeted following a report detailing disappointing Q4 and full-year 2025 financial results. The decline was attributed to significant reductions in 2025 EBITDA and a one-time inventory charge, leading to a rapid loss of investor confidence. The firm is encouraging affected investors to contact them to discuss their legal rights and recovery options.

https://www.globenewswire.com/news-release/2026/03/20/3259775/0/en/The-Chemours-Company-Investigated-by-the-Portnoy-Law-Firm.html

Brunswick Co. commissioners unanimously opposed Chemours’ Fayetteville expansion

The Brunswick County Board of Commissioners unanimously passed a resolution opposing Chemours' proposed expansion at their Fayetteville Works facility. This decision follows concerns from residents and environmental groups regarding increased PFAS contamination in the Cape Fear River watershed, which serves as a drinking water source for Brunswick County residents. Commissioners urged state regulators to deny the expansion permit and to focus on eliminating current PFAS discharges.

http://www.msn.com/en-us/news/us/brunswick-co-commissioners-unanimously-opposed-chemours-fayetteville-expansion/ar-AA1RAinm?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1

Chemours (CC) Shares Jump 9.4% as Analysts Raise Price Targets

Chemours (CC) shares surged 9.4% to $19.30 after three analyst firms raised their price targets for the specialty chemical maker by an average of 24% over the past three weeks. UBS, Goldman Sachs, and Mizuho all issued updated ratings and targets, indicating improving sentiment for Chemours' businesses. The increase in trading volume suggests strong institutional interest in the stock.

https://news.alphastreet.com/blog/2026/03/17/cc-why-moving/

Chemours Co. Hits Day High with Strong 7.65% Intraday Surge

The Chemours Co. experienced a significant 7.65% intraday surge, reaching a high of USD 20.08, vastly outperforming the S&P 500 recently. Despite strong short-term stock performance, including a 30.07% gain over the past year, the company faces long-term challenges such as a high debt-to-equity ratio of 13.88 and a negative return on equity of -4.80%, indicating ongoing financial concerns. Its stock has declined over a three and five-year period.

https://www.marketsmojo.com/news/stocks-in-action/chemours-co-hits-day-high-with-strong-765-intraday-surge-3899180

Trending Today

Super Micro Computer Inc ($SMCI) Stock Forecast: Up 8.1% Today

fuboTV Inc. ($FUBO) Stock Forecast: Down 5.1% Today

Centene Corporation ($CNC) Stock Forecast: Down 5.0% Today

Texas Roadhouse Inc. ($TXRH) Stock Forecast: Down 2.3% Today

NASDAQ-100 ($NDX) Index Forecast: Up 1.9% Today

Chegg Inc. ($CHGG) Stock Forecast: Down 3.2% Today

Micron Technology Inc. ($MU) Stock Forecast: Down 5.4% Today

Enphase Energy Inc. ($ENPH) Stock Forecast: Down 5.1% Today

Amylyx Pharmaceuticals ($AMLX) Stock Forecast: Up 1.6% Today

Solana ($SOL) Crypto Forecast: Up 5.5% Today

Chemours Company (The) Price History

04.02.2026 - CC Stock was up 5.1%

• The upward movement in CC's stock may be attributed to the favorable quarterly EPS results and outperforming expectations despite a decrease in revenue compared to the previous year.
• Actions like equity grants and share withholdings for tax obligations by Chemours executives may have boosted investor confidence in the company's future outlook.
• Following a stock price decline after the financial results, ongoing investigations by a legal firm might have initially caused market uncertainty, but positive performance indicators helped restore investor faith and drive the bullish movement.
• Despite Quantbot Technologies LP reducing its stake in Chemours, the company's dividend announcement and overall financial health likely reassured investors, contributing to the upward trajectory.

03.02.2026 - CC Stock was down 7.9%

• Stake reductions by Quantbot Technologies LP and Vanguard Group Inc. indicate a lack of confidence in the company.
• Negative sentiment is heightened by an ongoing investigation into the company following a stock price drop linked to one-time inventory charges and market challenges.
• Despite surpassing quarterly EPS estimates and achieving a positive return on equity, a year-over-year revenue decline may have contributed to the stock's bearish performance.
• The bullish outlook from FelixQE's Substack, emphasizing the company's undervaluation and growth potential amidst PFAS litigation, stands in contrast to prevailing market sentiment, indicating a divergence in investor perspectives.

20.02.2026 - CC Stock was down 5.0%

• Today's downward trend in CC's stock price could be linked to an investigation initiated by the Portnoy Law Firm into potential securities fraud, triggered by disappointing financial results in Q4 and full-year 2025. This development possibly eroded investor confidence, resulting in the stock decline.
• The Brunswick County Board of Commissioners' unanimous disapproval of Chemours' proposed expansion due to worries about PFAS contamination in the Cape Fear River watershed might have exacerbated negative investor sentiment, contributing to the bearish movement.
• Despite the adverse updates, the recent intraday stock price increase of 7.65% and a subsequent 9.4% rise following analysts' heightened price targets indicate some positive market sentiment. Nevertheless, enduring challenges like a high debt-to-equity ratio and negative return on equity are persisting factors impacting the stock's performance.

19.02.2026 - CC Stock was down 5.6%

• Today's significant bearish movement in CC's stock might be related to investors having a negative reaction towards the company's cautious capital allocation approach. This was highlighted by a debt refinance with higher coupon rates, an increase in CEO pay, and a dividend cut.
• Concerns have been raised among investors due to long-term challenges like a high debt-to-equity ratio and negative return on equity, which could have led to the stock sell-off.
• Although there has been positive short-term performance and an earnings beat as of late, investor sentiment may be impacted by ongoing PFAS liabilities and market risks, ultimately contributing to today's bearish market movement.

05.02.2026 - CC Stock was down 5.4%

• Analysts have raised their price targets for Chemours, showing optimism and positive expectations for the stock.
• An investigation into potential claims against Chemours following a stock price decrease due to a one-time inventory charge may have impacted the bearish movement.
• Reports of an executive receiving restricted stock units (RSUs) and shares being held for tax purposes might have also influenced investor sentiment.
• The contrasting information of price target increases and investigations into financial disclosures likely caused uncertainty and contributed to the downward trend in Chemours' market performance today.

27.01.2026 - CC Stock was up 5.5%

• Chemours (CC) experienced a bullish trend today due to investor focus on the company's new AI cooling partnership and analyst updates.
• The successful private offering of $700 million in senior notes due 2034 also contributed to the positive market movement.
• Despite concerns raised by a law firm regarding potential securities fraud and market headwinds, the company's undervaluation according to discounted cash flow models and price-to-sales ratios has helped reassure investors.
• The company's valuation and recent financial results have inspired volatility, but the overall market sentiment remains optimistic about Chemours' future prospects.

26.01.2026 - CC Stock was down 5.4%

• The bearish movement in Chemours (CC) stock today could be attributed to profit-taking by investors after a period of undervaluation.
• The increase in price targets by financial institutions may have initially boosted confidence in the stock, but the market sentiment might have shifted due to concerns about the company's negative net margin and P/E ratio.
• The joint development agreement with 2CRSi for advanced cooling solutions could be a positive long-term catalyst for Chemours, but short-term market dynamics might have overshadowed this news.
• Overall, the bearish movement in CC's stock today seems to reflect a mix of valuation concerns, profit-taking, and short-term market sentiment, despite promising developments in its technology partnerships.

23.02.2026 - CC Stock was up 5.0%

• The North Carolina Supreme Court reviewing a lawsuit against DuPont and Chemours may have introduced legal uncertainties and risks for the company, impacting market sentiment initially.
• An investigation into potential securities fraud by the Portnoy Law Firm following disappointing financial results likely contributed to CC's stock price decline.
• The subsequent increase in CC's stock price may be linked to three analyst firms raising their price targets for the company, indicating improved sentiment and potentially attracting more institutional investors.
• The strong intraday surge and outperformance of the S&P 500 suggest a positive short-term market response to the raised price targets and overall analyst enthusiasm, despite CC's enduring financial challenges and environmental issues.

17.02.2026 - CC Stock was up 7.5%

• Reasons for the recent strong stock performance of Chemours include:
• Reduction of 77.6% in Cinctive Capital Management LP's stake, signaling a shift in positions.
• Successful completion of a $700 million private offering of senior unsecured notes due 2034, bolstering investor trust in the company's financial structure.
• Despite worries about PFAS liabilities and market risks, the company exceeded Q3 earnings expectations with $1.33 billion in revenue and maintained a quarterly dividend, painting a positive picture for investors.
• Discordant fair value assessments and differing opinions on the company's actual value may have led to stock price volatility, prompting today's upward movement as investors reevaluate their positions in light of the latest developments.

17.02.2026 - CC Stock was up 6.0%

• Chemours opted to refinance existing debt through the issuance of $700 million in senior unsecured notes due 2034. Despite a higher coupon rate, extended maturities, and a dividend cut, this move reflects a prudent capital allocation strategy amidst ongoing PFAS liabilities and market risks.
• The disparity in fair value signals for the stock adds to investor uncertainty. While a DCF model indicates an undervaluation at $49.99, a different valuation pegs it at $16.33, creating the need for thorough due diligence.
• Wolf Hill Capital Management LP's recent acquisition of a stake in Chemours, combined with positive Q3 earnings and a consensus "Hold" rating from analysts, has fueled market optimism. Investors seem confident in the company's potential for future growth.
• The successful completion of a private offering for $700 million in senior unsecured notes due 2034, aimed at optimizing the balance sheet by refinancing existing obligations and funding note redemptions, has further buoyed investor sentiment and propelled the stock's upward trajectory.

10.02.2026 - CC Stock was up 7.1%

• Factors contributing to CC's stock price surge include:
• A strong earnings per share (EPS) beat and the company's announcement of a quarterly dividend, potentially boosting investor confidence.
• Despite encountering obstacles like a one-time inventory charge and short-term market challenges, the stock demonstrated resilience and attracted new institutional investors.
• Positive technical indicators hinting at a bullish to mildly bullish trend for the stock likely heightened traders' optimism.
• Despite initial uncertainties surrounding an investigation, investors appear positive about CC's future prospects based on the stock's performance.

09.02.2026 - CC Stock was up 5.0%

• An inquiry triggered by a specific firm in response to the stock price drop may have rattled investors initially, yet subsequent market activity indicates a more positive investor sentiment.
• The increased institutional investments from Neo Ivy Capital Management and American Century Companies Inc. signal a growing belief in Chemours' long-term prospects, despite varied analyst evaluations and recent downward revisions in earnings forecasts.
• Chemours' adoption of Adobe Marketo Engage to enhance marketing outcomes demonstrates a commitment to expansion and customer interaction, potentially contributing to the recent positive market trends.
• While short-term hurdles may have affected Chemours' stock value, the company's strategic efforts and investor trust appear to be propelling the recent market upswing.